A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
about
Systemic antifungal therapy for tinea capitis in childrenSystemic antifungal therapy for tinea capitis in childrenItraconazole in the treatment of tinea capitis caused by Microsporum canis: experience in a large cohort.Update on terbinafine with a focus on dermatophytosesTherapeutic options in the treatment of tinea capitis.Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycin.Tinea capitis in infants: recognition, evaluation, and management suggestionsCurrent use of anti-infectives in dermatology.Dermatophytosis: the management of fungal infections.Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis.A double-blind randomized placebo-controlled clinical trial of squalamine ointment for tinea capitis treatment.British Association of Dermatologists' guidelines for the management of tinea capitis 2014.Management of tinea capitis in childhood.Preanalytical conditions for broth microdilution antifungal susceptibility of Microsporum spp.Kerion Celsi in a newborn due to Microsporum canis.
P2860
Q24185768-7646F465-8F66-4254-A848-8CC12948F27CQ24243038-962B730D-9283-415A-9B51-571B57EF179BQ34337257-BC9D6D32-28D5-4486-9040-892566E17FEFQ34620230-2EA75F9C-F052-44F2-A3AA-D3ED15C9E233Q35680563-7CBEA9C1-3060-443C-9FEA-D4A43C9FF308Q35680566-8767433B-01FB-4B17-BEFD-6E2DE0B6E874Q35862129-5D1B6961-7D56-448C-AC04-2AB3AE26629AQ36233506-7B04506D-FE01-4DA0-822F-C10BC55D5AC3Q36311283-0CDF0260-9408-4EE9-A560-DC264FE72B97Q38044927-732627DF-B8F6-43A0-81D4-1165F5890A65Q41595737-073207D7-FA19-4DD4-9223-0A27E48DF3D4Q41734204-414E1E4E-8545-482D-B38F-60AC695236B7Q42647869-C970B15C-2259-42DE-8B15-C3E7337FEB04Q44657018-8642E3EB-C79B-495B-BC1A-D804CAD95CFBQ44930557-7742D340-A6BE-4B6E-B3EC-51B52E535BAA
P2860
A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
A randomized, double-blind, pa ...... is due to Microsporum species.
@en
A randomized, double-blind, pa ...... is due to Microsporum species.
@nl
type
label
A randomized, double-blind, pa ...... is due to Microsporum species.
@en
A randomized, double-blind, pa ...... is due to Microsporum species.
@nl
prefLabel
A randomized, double-blind, pa ...... is due to Microsporum species.
@en
A randomized, double-blind, pa ...... is due to Microsporum species.
@nl
P2093
P2860
P1476
A randomized, double-blind, pa ...... is due to Microsporum species.
@en
P2093
J Lipozencic
N Gourmala
R Orofino-Costa
Tinea Capitis Study Group
P2860
P304
P356
10.1046/J.1365-2133.2002.04744.X
P407
P50
P577
2002-05-01T00:00:00Z